1. Introduction {#s0005}
===============

Microbiological risk assessment is part of an established framework for risk analysis that consists of the following steps: statement of purpose, hazard identification, hazard characterization, exposure assessment and risk characterization ([@bb0060]). In the field of food safety, a 'farm to fork' quantitative risk assessment (QMRA, Quantitative Microbial Risk Assessment) approach is often applied to assess the public health risk for a particular pathogen/matrix combination (e.g. [@bb0290]). Transmission of the pathogen (e.g. *Campylobacter* spp.) through a specific food production chain (e.g. poultry) may be quantified using a probabilistic QMRA model (e.g. [@bb0225]). Variability and/or uncertainty in the pathogen prevalence, concentrations and food production process properties are included as model parameters. Monte Carlo simulations, or other probabilistic techniques, are used to predict public health risk and the effect of different intervention strategies can then be calculated to support industrial or governmental decision making (e.g. [@bb0255]). Systematic sensitivity analyses can be used to indicate the value of new evidence but only at the level of detail that was used during the model construction.

Since the introduction of high-throughput DNA sequencing technologies, however, food microbiology has moved beyond the assessment of microbial behavior in different food processes for agents classified at (sub)species and serovar level. Moreover, with the rapidly dropping costs of sequencing, whole genome sequencing (WGS) will soon become a standard surveillance technique for the subtyping of isolates for epidemiological purposes. Although the use of molecular data has proved to be a powerful tool in decision making during outbreak investigations ([@bb0070; @bb0300]), the application of this data in microbiological risk assessment is currently an unexplored area in the public health domain. In recent years, a number of reviews and opinions have been published exploring the potentials of 'omics techniques' for MRA ([@bb0005; @bb0050; @bb0055; @bb0125; @bb0260; @bb0265]) but, evidence based research, as a first step to convert these heuristic approaches into normative tools for practical use, is still needed.

The difficulties associated with using molecular data for food safety risk assessment are complex but are related to the prescribed framework and the current methodology which generally expresses a large (but closed) joint probability to represent a 'farm to fork' hazard domain. For example, where the variability and/or uncertainty of concentration and prevalence data are relevant in QMRA these can be described by probability distributions but it is not clear how to use this approach when the data consists of a genome sequence. Firstly, new technologies provide information at a completely different level of description (genes or their products) that makes their joint probability, in its simplest form, unmanageable. Secondly, the new description does not, in the first instance, provide a clear connection between the observed quantities and the output measures, such as survival or health impacts, that are the object of risk assessments. So, for decision support, the biggest challenge facing genomics is the prediction of phenotypic properties of a particular pathogen within a food chain based on genotypic data. An understanding of systems biology is needed, as the organizational principle in pathophysiology, to describe the relation between the new level of genetic sequence data and the health end points of concern. Whereas in the established framework for risk assessment the elements of a joint probability are considered to be known, or knowable, the introduction of a new level of description and a systems property leads to elements of a joint probability that cannot easily be formulated and to dependencies that are not easy to identify. To reduce the numbers of possible relations and translate genetic sequence into phenotypic properties, an understanding of pathogen physiology is needed. Currently, such understanding is incomplete and consequently the mapping of genetic sequences onto a quantitative description of risk is problematic: the number of genes outweighs the number of strain samples by many orders of magnitude. It should be clear that statistical analysis of WGS data is non-trivial, and that reproducible and meaningful associations between gene variability and phenotypic properties need to be established before genetic data can be used for decision making in food safety.

As indicated during EFSA\'s 20th scientific colloquium ([@bb0090]), a diversity of exemplary data analyses need to be developed and shared within the scientific community to allow for the identification and appreciation of "best practices" in moving forward from current methodology. A (theoretical) methodology for hazard identification is proposed that uses WGS data analysis to link genomic sequences with phenotypic behavior for Shiga toxin-producing *Escherichia coli* O157 (STEC O157) as a case study. This is achieved by the integration of genomic (single nucleotide polymorphism (SNP) genotypes) data with phenotypic (attachment to epithelial cells) information and with epidemiological data (outbreak strains and the epidemiological relationship with sporadic cases) in a Genome Wide Association Study (GWAS).

The aim of this study is to introduce a method for hazard identification that links WGS data with results on in vitro adherence to epithelial cells as a proxy for virulence using a subset of STEC O157 isolates as a case study. An explanation of the concepts, identification of the value of the methodology and a relationship with the public health domain are supported by a thorough discussion of further research needs. This paper identifies a necessary paradigm change in public health microbiological risk assessments.

2. Materials and methods {#s0050}
========================

2.1. STEC O157 as a case study {#s0055}
------------------------------

STEC is of public health concern because of its ability to cause outbreaks and severe disease such as hemorrhagic colitis (HC) or hemolytic--uremic syndrome (HUS). Currently, different STEC serogroups are placed in different risk classes (i.e. seropathotypes) based on their epidemiological association with severe disease and outbreaks ([@bb0135]). However, this system is of limited use for two reasons. First, it is retrospective, only including known types. Secondly, the pathogenicity of STEC cannot be predicted from the serotype alone. Numerous (putative) virulence genes have been associated with increased disease severity and individual strains of STEC can differ considerably in their virulence profile and, consequently, in their pathogenic potential ([@bb0075]). Gene association studies are normally conducted by linking the genetic content of the strain to the seropathotype or more specific to the clinical symptoms it caused ([@bb0015; @bb0245]). However, these association studies might be confounded by food and host effects. Within serogroup O157 considerable attention has been given to the non-random distribution of genotypes among bovine and human clinical isolates, showing considerable genome divergence ([@bb0120]). However, observed non-random distribution of clades and lineages among bovine and human clinical isolates might be the result of a differentiation in virulence, transmission capacity and survival, or some combination ([@bb0115]). For a better understanding of STEC O157 risks, these (or other) potential causes should be investigated separately. Recently it was shown that the environmental exposure route selects for strains characterized by the absence of mutations in the general stress response system *rpoS*, which are subsequently more likely to survive the human gastric barrier ([@bb0110; @bb0315]).

The evaluation of intrinsic differences in virulence requires a standardized model system. Several animal models for STEC disease exist and their value is clearly recognized ([@bb0220]). However, for technical, economic, and ethical reasons, in vitro models offer a relevant alternative to in vivo studies. Although more distinct from a human system, in vitro models offer more stability in terms of reproducibility ([@bb0030]). The combination with WGS information subsequently allows for genotype--phenotype matching and comparative genomics of strains in order to identify genetic elements that differentiate highly virulent strains from less virulent ones. Analysis at the SNP level is a straightforward approach to extracting elementary information on genotype, and will be used in this study.

2.2. *E. coli* O157 strains {#s0060}
---------------------------

In an earlier study the frequency of *E. coli* O157 genotypes among 73 bovine, 29 food, and 85 human clinical isolates was determined in The Netherlands ([@bb0115]). The results demonstrated that O157 lineages (as defined by the lineage specific polymorphism, or LSPA, assay) were non-randomly distributed among isolates of bovine and clinical human origin. A selection of in total 38 human and animals strains from different LSPA lineages was selected for further investigation in this study ([Table 1](#t0005){ref-type="table"}).

2.3. Genotypic data {#s0065}
-------------------

Whole genome sequences of the 38 *E. coli* O157 were obtained using the Illumina MiSeq platform with 2 × 150 (human isolates) and 2 × 250 (animal isolates) paired end runs.

The genomic sequence of a human Shiga toxin-producing *E. coli* O157:H7 strain isolated during the Sakai outbreak which occurred in Japan during 1996 was used as a reference. The short sequencing reads were mapped onto the reference chromosome (accession number: [NC_002695](ncbi-n:NC_002695){#ir0020}) and its large plasmid pO157 (accession number: [NC_002128](ncbi-n:NC_002128){#ir0025}) using the alignment tool *BWA* ([@bb0165]). The *SAMtools* software package converted the SAM format files to BAM format and sorted the BAM files ([@bb0170]). SAMtools mpileup generated BCF format files and bcftools was used to call the SNPs (between reference and samples) in VCF format. SNPs were filtered with the quality threshold set at a minimum read depth of five. SNP data were transformed to binary, 0/1, data. Those sites where a SNP was identified in the STEC strains under study (test strains) compared to Sakai (reference strain) received a 1. A 0 was placed accordingly for identical nucleotides on the genome of each test strain compared to the reference strain Sakai. This resulted in a binary *m* by *n* matrix, where *m* is the number of SNPs and *n* the number of test strains (*n* = 38).

2.4. Phenotypic data {#s0010}
--------------------

The adhesive properties to human intestinal cells were used as a proxy for virulence in this study. In total, 18 human O157 isolates (H-numbers) and 20 animal O157 isolates (A-numbers) from lineage I, I/II and II (see [Table 1](#t0005){ref-type="table"} for strain properties) were investigated and compared. Differentiated Caco-2 cells were used as a representative model system for human intestinal cells. They were produced, treated and seeded as previously described by [@bb0235]. For adhesion experiments the cells were seeded in 12-well plates at a concentration of 1.6 × 10^5^ cells/well. Each STEC strain was inoculated in BHI broth and incubated overnight (ON) at 37 °C to obtain a culture consisting of approximately 10^9^ CFU/ml. Subsequently, three decimal dilutions resulting in a STEC suspension of each strain of approximately 10^6^ CFU/ml were made. From these last suspensions, Caco-2 cells in 12-well plates were inoculated with 40 μl per well, per STEC strain six wells. Plates were centrifuged (1 min at 175 × *g*) and incubated at 37 °C in a humidified atmosphere of 95% air and 5% CO~2~ for 1 h.

After incubation and three washings with pre-warmed sterile phosphate-buffered saline (PBS), 1 ml 1% Triton-X100 in PBS (pre-warmed) was added to each well to detach the cells.

The detached cells were collected and the contents of three wells were combined. Decimal dilutions were prepared in peptone physiological salt solution, and the dilutions were plated on Brilliance™ *E. coli*/coliforms Selective Agar (Oxoid, Badhoevedorp, The Netherlands).

3. Statistical data analysis {#s0070}
============================

3.1. Phenotypic data {#s0015}
--------------------

The fractional adherence was calculated by dividing the number of STECs after the adhesion assay by the number of STECs added to the Caco-2 cells. If cells are assumed to be homogeneously distributed in the ON culture, then the number of cell counts per dilution is Poisson distributed with a parameter *λ*. Based on this assumption, the best estimate for λ, the expected number of cells in a sample, can be estimated from counts in serial dilutions of the original sample according to $\frac{\sum_{i = j}^{k}n_{i}}{\sum_{i = j}^{k}10^{- i}}$, where *n* is the number of counts in the *i*th dilution. The point estimate for the fraction of bacteria attached to the Caco-2 cells is $\frac{\lambda_{2}}{\lambda_{1}}$, where *λ*~1~ is the expected number of bacteria in the overnight culture and *λ*~2~ is the expected number of bacteria attached to the Caco-2 cells.

3.2. Simple linear regression {#s0020}
-----------------------------

The basic idea in this study is to identify SNPs in the test strains that could be associated with an increased virulence behavior (represented by relatively high Caco-2 cell attachment fractions compared to other test strains without these SNPs).

The strength of this association can, in the most basic form, be estimated using the following simple linear regression model for each SNP:$$y_{i} = \ \mu + \beta x_{i} + \ \varepsilon_{i}\ \text{,}$$where*y*~*i*~ is the fractional Caco-2 adhesion for strain *i*, *μ* is the mean response, *β* is the SNP effect, *x*~*i*~ is an indicator variable with $x_{i} = \left\{ \begin{array}{l}
{0\mspace{22mu}{if}\ {the}\ {marker}\ \left( {{here},\ SNP} \right)\ {score}\ {of}\ {test}\ {strain}\ i\ {is}\ {equal}\ to\ {the}\ {reference}\ {strain}} \\
{1\mspace{22mu}{otherwise}\text{,}} \\
\end{array} \right)$ and the residual errors, *ε*~*i*~ , have independent normal distributions with variance *σ*~*e*~^2^.

For each SNP the null hypothesis *H*~0~ : *β* = 0 is tested against an alternative hypothesis *H*~*a*~ : *β* ≠ 0 and the P-values and effects *β* are calculated and transformed to a − log10 scale.

In Genome Wide Association Studies (GWAS) a corresponding test is applied for all markers. In terms of hazard identification this simplified model would assign strains to one of two classes of hazards, with different rates of adhesion, depending on the presence of a single SNP.

There are several issues in GWAS studies that are more complex than in standard linear regression. First of all, as the number of SNPs (*m*) outweighs the number of test strains (here, *n* = 38) one has to correct for multiple testing. If a standard 5% significance threshold per marker is used, there will be many false positives. One solution is to use a Bonferroni correction ([@bb0145]), using a genome wide significance threshold of *α*/*m*. A second problem in GWAS is that the minor allele frequency (MAF) has to be high enough, i.e. we cannot use markers where almost all the markers are equal to the reference strain (score 0), or where almost all the markers are different from the reference strain (score 1). A third problem with a simple linear regression model is more complicated: there is no correction for population structure. In the next section a solution for this will be presented by using a more complicated statistical model called a mixed model.

3.3. Correcting for population structure using mixed effect models {#s0025}
------------------------------------------------------------------

The problem with population structure can be explained with a simple example: suppose there are two groups of strains, A and B, with small genetic differences within groups, and a large genetic difference between groups. Then most SNP scores will follow the same pattern. That is, SNP scores will be attributable to differences in the groups rather than the difference in adherence capacity. As a consequence, the linear regressions will also be quite similar. In other words, in the case where one has two clearly separated groups one is mainly testing for differences between groups, not within groups. In such an example with two clear groups A and B, an extra term in the regression model can be used to correct for group effect, that is$$y_{i} = \ \mu + \beta x_{i} + gz_{i} + \varepsilon_{i}\ \text{,}$$

where the parameter *g* is the group effect, and *z*~*i*~ indicates whether strain *i* is in group A or B. With this correction for group effect one can test for SNP effects along the genome, i.e. testing for each SNP the significance of parameter *β*. A similar approach can be used in situations where there are strains which can be subdivided in several groups ([@bb0150; @bb0275]).

In many cases, however, there is not such a clear separation into different groups. A way to check this is by calculating the similarity between the strains. For each pair of strains, the fraction of SNPs that have the same marker score can be calculated, resulting in an *n* × *n* similarity matrix *K.*

The similarity matrix may be used to correct for population structure ([@bb0190; @bb0240; @bb0330]). A solution that is often used is a mixed effect model approach:$$y_{i} = \ \mu + \beta x_{i} + G_{i} + \varepsilon_{i}\ \text{,}$$

where (*G*~1~, *G*~2~, ..., *G*~*n*~) follows a multinormal distribution, *G*~*i*~ \~ *N*(0, *σ*~*g*~^2^*K*), and *σ*~*g*~^2^ is the genetic variance. This model is used to test for the significance of the SNP effects, *β*, along the genome.

4. Results {#s0030}
==========

The fractional adhesion of the STEC O157 strains to Caco-2 cells is highly variable with a frequency distribution resembling an overall skewed distribution (average 0.16, median 0.11). Higher fractions are more rare and concentrated in the human strains ([Fig. 1](#f0005){ref-type="fig"}). Mapping of the individual sequences to the reference genome resulted in the identification of 27,980 SNPs among the total set of 38 test strains. When the totality of identified SNPs was used to infer the population structure, at least three separate populations could be identified ([Fig. 2](#f0010){ref-type="fig"}). [Fig. 2](#f0010){ref-type="fig"} shows the principal coordinate plot of the 38 strains, with 12.4% of the variance explained by the first axis, and 8.9% by the second axis. The three identified populations in [Fig. 2](#f0010){ref-type="fig"} reflect the LSPA lineages within STEC O157 (LI, LI/II and LII) as described by [@bb0115].

After application of the most basic linear regression model (without correcting for population structure), 17 SNPs appeared to be significantly associated with increased adherence to Caco-2 cells ([Fig. 3](#f0015){ref-type="fig"}, [Table 2](#t0010){ref-type="table"}). That is, using a MAF ≥ 0.05 and a significance level α \~ 10^− 4^, 17 positions on the chromosome of the reference strain show a positive linear relation between SNPs identified in the test strains when comparing fractional adhesion to Caco-2 cells with that for the Sakai reference.

[Table 3](#t0015){ref-type="table"} shows the loci and, if known, information on biological function, associated with the significant SNPs (SNPs having a MAF ≥ 0.05 and, in bold face, MAF ≥ 0.1, i.e. ID 8, 9 and 15) as presented in [Table 2](#t0010){ref-type="table"}. As explained above, instead of having any biological relevance, the results in this SNP analysis could also be the product of a type I error. That is, identifying significant association between genotypic (SNP) and phenotypic (fraction adhesion) information, where there is none.

Having said this, the 17 SNPs identified warrant further investigation with respect to their role in virulence and their use as risk markers for hazard identification. Of these 17 SNPs, eight were non-synonymous in protein-coding regions ([Table 3](#t0015){ref-type="table"}). These SNPs change the protein-sequence and thereby potentially the function of the product.

[Table 4](#t0020){ref-type="table"} shows which test strains were responsible for the significant effects (identified in [Table 2](#t0010){ref-type="table"}, [Fig. 3](#f0015){ref-type="fig"}) with the corresponding fractional adhesion to Caco-2 cells. Here the problem associated with a low MAF (identified in the [Statistical data analysis](#s0070){ref-type="sec"} section) becomes visible. Setting the MAF threshold at 0.05 will result in a significant effect when two (or more) test strains appear to share a SNP and are associated with a relatively high (or low) fraction of attachment compared to the test strains that do not differ from the reference Sakai strain for that site. The result of a type I error in multiple testing (here 27,980 tests) and/or not correcting for population structure may be the cause of this effect.

When correcting for population structure one SNP appears to have a significant effect in this GWAS ([Fig. 4](#f0020){ref-type="fig"}). The identified SNP position is 3,115,507 which is close to ID 11 in [Table 3](#t0015){ref-type="table"} and also has an intergenic position, which in many cases might be irrelevant, but could still be related to promoter sequences.

5. Discussion {#s0035}
=============

Microbiological risk assessment is intended to support decision making in the farm to fork food production chain. Currently food safety criteria are implemented at many levels down to serovar/serotype level for some pathogens (e.g. absence of *Salmonella* Typhimurium and *Salmonella* Enteritidis in fresh poultry or STEC O157, O26, O103, O111, O145 and O104:H4 in sprouts). From this perspective it is difficult to assess how the increasing amount of new (molecular) data will influence decision making. Does a 'new' genotype identify a new hazard and thus require a change in policy? And, how should the presence/absence of a virulence gene influence the hazard characterization? There are many such questions and probably even more possible answers related to this problem which can, in general, be referred to as disaggregation. For example, if for a previous 'generalized' pathogen (e.g. a serotype) additional information can be specified to describe two 'less general' pathogens there is an increase in the number of hazards. This increase is exponential because all possible combinations may be relevant. Obviously, when this argument is stretched to the full sequence specification, the disaggregation catastrophe is clear. There will never be enough risk assessments to quantify and predict the full spectrum of all risks. On the other hand, two different subtypes of a 'generalized' pathogen may have identical virulence, and their distinction is irrelevant for public health. So, an 'organization principle' as a basis for priority setting of highly pathogenic strains is a necessary prerequisite for risk assessment developed from WGS information. This is why linking genotypic with phenotypic properties is essential as it will help to identify *high risk* isolates from the full spectrum of strains obtained by WGS. In addition, methods for clustering may further reduce the total number of hazards to manageable proportions, for both risk scientists and risk managers. A decisive factor in specifying the clustering level of WGS information is having a good definition of the statement of purpose for the risk analysis. This and insight in the main biological process underlying the risk (e.g. surviving process conditions, the time to initiate growth or invasion of gut epithelium) will guide the data requirements (e.g. expression data, (single) cell growth or SNP data for marker identification).

For this case study, the purpose was to improve hazard identification for STEC O157. The first obvious step in the 'organization principle' was to identify a measure for virulence, here adhesion to the gut epithelium. The next step in identifying high risk isolates was discovery of an association between this important virulence factor and genome sequences (i.e. SNP data) for different STEC O157 strains. A further biological analysis of the identified associations may attribute some part of the biological variation (here, fractional attachment) to the activity of the specific genes corresponding to the 'significant' SNPs.

5.1. Biological relevance of identified SNPs {#s0040}
--------------------------------------------

A potential biological relevance can be ascribed to the eight non-synonymous SNPs that are significantly (MAF ≥ 0.05 and a significance level, α \~ 10^− 4^) associated with higher in vitro adherence to the epithelial cells using the simple linear regression model ([Table 3](#t0015){ref-type="table"}). ECs2332 encodes for a [l]{.smallcaps}-arabinose 1-dehydrogenase (family of oxidoreductases). [l]{.smallcaps}-Arabinose is generally well utilized as a sole carbon source by *E. coli* O157 strains ([@bb0110]) and the intestinal niche occupied by pathogenic *E. coli* O157 strain EDL933 has been shown to be largely defined by the utilization of arabinose for colonization ([@bb0095; @bb0195]). Phenotypic characterization revealed that mutations in the stringent response system resulted in defective utilization of [l]{.smallcaps}-arabinose ([@bb0230]). The ECs5283 locus represents the DNA-binding transcriptional repressor UxuR which plays a role in the [d]{.smallcaps}-glucuronate metabolism of *E. coli* and has been shown to be necessary for maximum ability of *E. coli* to colonize the intestine ([@bb0065]). ECs4969 is a putative phage portal protein, which forms a key component during viral chromosome packaging. Although the same locus was found to be significantly upregulated upon exposure of *E. coli* O157 to apple juice ([@bb0020]) the role in pathogenicity remains elusive. Sequence divergence of the phage borne antitermination gene *Q* (ECs1203), located upstream of *stx*~2~, has been associated with variation in transcription of *stx*~2~ and with a nonrandom distribution among bovine and human isolates ([@bb0115; @bb0160]). The same locus was shown to be significantly up-regulated in a lineage (clade 8) of *E. coli* O157:H7 commonly associated with human infections ([@bb0010]). Recently, [@bb0320] proposed a model in which Stx2 promotes epithelial cell colonization. Since the antitermination gene *Q* controls the level of Stx2 production, this gene is a potential candidate for an increased attachment marker. The *rhs* genes are rearrangement hot spots within *E. coli* and appear to be under strong positive selection ([@bb0250]). Their extracellular nature may result in a strong positive selective pressure from the host\'s immune system and may therefore be involved in O157 host specificity ([@bb0180]). They have been reported to promote intestinal colonization of calves ([@bb0305]).

Bioinformatic analyses support the conclusion that bacterial Rhs proteins commonly carry toxin domains and it is proposed that contact-dependent growth inhibition is the primary function of these proteins ([@bb0130]). However, Rhs also appears to coordinate multicellular behavior and biofilm formation ([@bb0270]). Interesting however is the fact that sequence diversity in *rhs* is also linked to the differentiation of STEC O157 into different clades which in turn have different associations with epidemiology ([@bb0180; @bb0200]). The *rhs* should be further investigated with respect to combined relevance for biological functioning, phylogeny and epidemiological relevance.

5.2. Advantages and limitations of the approach {#s0045}
-----------------------------------------------

Traditionally, STEC hazard identification is based on the seropathotype (SPT) concept of classifying STEC serogroups into different risk classes based on their epidemiological relevance (i.e. severity of disease and involvement in outbreaks) ([@bb0135]). Although informative as an ex post facto determinant of virulence potential, the dynamic nature of STEC virulence in time and place exposes a limitation of SPT classification as a predictive indicator of microbial risk. The approach described here, matching in vitro adherence to epithelial cells as a proxy for virulence with SNP data offers a standardized, reproducible, serogroup independent method for identifying potential candidate genes to be included in epidemiological association studies or more refined hazard identification. Additionally the analysis does not become rapidly unmanageable as more strains are included. SNP analysis of a broad spectrum of isolates (from different sources that are not necessarily associated with human cases) may lead to a less biased association between genotypic and phenotypic strain characteristics. Still, the identification of significant SNPs associated with in vitro virulence should be treated with some caution for several reasons.

First, the in vitro adherence of O157 to human epithelial cells was used as a proxy for in vivo virulence. However, it should be noted that adherence to epithelial cells is only one aspect of the etiology of O157 infection in humans. Although the production of Shiga toxins is the main virulence factor responsible for the more severe symptoms, adherence to the gut epithelium is an important first step in the etiology of STEC infections. The production of Shiga toxins (on expression level, produced toxin level, and/or effect on Vero cells) could be added to this framework and can be analyzed in the same way (with a focus on the prophage regions). Second, SNP analysis based on comparing test strains with one reference strain (here, *E. coli* O157 strain Sakai) cannot identify SNPs that might be of relevance for hazard identification, but have sequences that are not present in the reference strain. Reference to the pan genome of STEC O157 or even STEC in general could account for this omission ([@bb0155]). Alternatively, a "gene-by-gene" approach could be adopted in which the presence/absence of all genes is scored as well as the allelic variation within each gene ([@bb0185]).

Third, instead of having any biological relevance, the results in this SNP analysis could also be the product of a type I error. That is, identifying a false positive association between genotypic (SNP) and phenotypic (fractional adhesion) information, where there is none. This problem will often occur in SNP analysis for MRA where the number of SNPs usually outweighs the number of phenotypic observations. Setting the MAF threshold to a higher level, e.g. 0.1, could alleviate the problem of the small population size. [Table 2](#t0010){ref-type="table"} shows that 'only' three positions on the chromosome of Sakai will be identified as being significant when a MAF ≥ 0.1 would be applied in this study. These represent two loci on the reference genome, i.e. ECs2164 and ECs4864 associated with 'minor tail protein encoded by prophage CP-933O' and 'RhsH protein' respectively ([Table 3](#t0015){ref-type="table"}). These are, however, non-synonymous SNPs. A further correction for population structure reveals one significant SNP position (3,115,507 which is intergenic) of potential relevance for further biological investigation.

Third, although the loci in which SNPs occur are potentially candidate marker genes for increased adherence to epithelial cells (and maybe virulence in general), the molecular postulates have to be fulfilled in order to prove causal relations ([@bb0105]).

Finally, the presence of a biomarker (e.g. SNP, gene, metabolite, protein) may by itself not always be a good predictor for risk, since the expression is influenced by a large variety of (dependent biological) factors.

Beside practical implications, this case study also gives insight into which basic statistical elements need to be considered before an association can be a subject for further analysis. That is,1.The power for analysis needs to be sufficient in order to be able to detect an effect.2.An optimal number of strains need to be established to get a representative view of the whole (molecular) population.3.One should correct for population structure before proceeding with further molecular data analysis.

For now, the number of strain samples is very limited for GWAS purposes, and the aim is to continue combining not outbreak biased genotypic with phenotypic STEC O157 data to build a valid statistical model.

Biological confirmation is an essential step before 'significant' SNPs can be identified as the cause of hazardous strains. This process consists of,1.Deletion and complementation studies (according to the principle of Koch\'s molecular postulates) to establish the causal relationships.2.Quantification and calibration of how many differences (e.g. SNP variants) between genomes will lead to treating them as separate categories needs to be established.3.Reproducibility of the analysis (both experimental and statistical) is a prerequisite for assigning any SNP with a biological relevance. This involves both biological and technical replicates to address variability in the phenotypic response during the statistical analysis.4.Linking epidemiological data to show the study how disease outcomes following infection are determined by the pathogen or by host factors. Human cases caused by any of the isolates with known phenotype can be used to study the association between phenotype (e.g. adherence to the gut epithelium, and growth rate) and disease outcome in humans. The inclusion of outbreak strains facilitates this construction.

Finally, applying the outcomes of statistical associations (confirmed by reproducible data) to microbiological risk assessment, raises the following issues:1.Integration. A systems biology approach is probably the best way forward to make a link from single scale in vitro testing to a multiple scale interpretation of effects.2.Anchoring. Translation of molecular investigations to human health risk is still a challenge.3.Communication. Current policy strategies (e.g. target setting) are based on serovar/serotype level research. This will only change when (statistically) validated model systems can be applied in the domain of public health food safety.4.Technology. Although not fully expressed in this study, there is a need for development of 'open data' systems to support rapid progression. The increasing generation of high throughput data on a global scale needs a central (sentinel) organization to facilitate comparison of risk relevant outputs from individual investigations.

6. Concluding remarks {#s0075}
=====================

The bottleneck in the application of molecular tools for microbiological risk assessment has shifted from data acquisition (costs, time) to data analysis and systems approaches. The inability to draw systematic conclusions from this study to STEC in general, represents a bottleneck in the flow of large volumes of WGS data into food safety knowledge. This has, in more general terms, been described by [@bb0045]. The paradigm change involves the translation of multidimensional information on genotype level (in the order of over 10^3^ genes, 10^4^ SNPs, etc.) via reduced information on phenotype level (in the order of 10^1^ biologically relevant characteristics for MRA, like growth rate, survival, attachment to the gut epithelium, and acid tolerance) to a single measure of risk, such as the number of human cases of illness. Future computational assessments of genetic data should aim at solving this mapping problem without losing biologically relevant information for MRA. Not until then can risk assessors provide reliable answers from WGS data to the posed health questions of a policy maker in an accessible manner.
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![Principal coordinate plot of the similarity matrix *K*. For each pair of strains the similarity was calculated as the fraction of SNPs that have the same score. Black, blue and red dots represent lineage I, I/II and II STEC O157 strains respectively.](gr2){#f0010}

![GWAS plot for trait fractional adhesion to Caco-2 cells. In this plot there is no correction for population structure, i.e. highly overestimating the number of true significant SNP effects.](gr3){#f0015}

![GWAS plot for trait fractional adhesion to Caco-2 cells, with correction for population structure using a mixed model. There is one significant SNP, at position 3,115,507, with effect β = 0.09, and − log10 (P-value) = 2.28.](gr4){#f0020}

###### 

*E. coli* O157 strains (n = 38) used in this study and some of their genetic characteristics.

  Strain   Source   Year   LSPA[a](#tf0005){ref-type="table-fn"}   *stx* gene(s)                    Intimin (*eae*)   *tir* (A255T)[b](#tf0010){ref-type="table-fn"}   clade 8[c](#tf0015){ref-type="table-fn"}   SBI[d](#tf0020){ref-type="table-fn"}
  -------- -------- ------ --------------------------------------- -------------------------------- ----------------- ------------------------------------------------ ------------------------------------------ --------------------------------------
  H06      Human    2005   I                                       *stx*~2a~                        \+                T                                                −                                          na[e](#tf0025){ref-type="table-fn"}
  H07      Human    2005   I                                       *stx*~2a~                        \+                T                                                −                                          na[e](#tf0025){ref-type="table-fn"}
  H09      Human    2005   I                                       *stx*~2a~                        \+                T                                                −                                          na[e](#tf0025){ref-type="table-fn"}
  H13      Human    2006   I                                       *stx*~2a~                        \+                T                                                −                                          3
  H15      Human    2006   I                                       *stx*~2a~                        \+                T                                                −                                          3
  A42      Bovine   2002   I                                       *stx*~2a~                        \+                T                                                −                                          3
  H25      Human    2006   I/II                                    *stx*~2c~                        \+                T                                                −                                          1
  H27      Human    2006   I/II                                    *stx*~2a~                        \+                T                                                −                                          1
  H42      Human    2007   I/II                                    *stx*~2a~, *stx*~2c~             \+                T                                                \+                                         1
  H44      Human    2007   I/II                                    *stx*~2a~                        \+                T                                                −                                          21
  H48      Human    2008   I/II                                    *stx*~1~, *stx*~2c~              \+                T                                                −                                          16
  H49      Human    2008   I/II                                    *stx*~1~, *stx*~2c~              \+                T                                                −                                          6
  H83      Human    2009   I/II                                    *stx*~1~, *stx*~2c~              \+                T                                                −                                          16
  A25      Bovine   2008   I/II                                    *stx*~2c~                        \+                T                                                −                                          21
  A37      Bovine   2007   I/II                                    *stx*~1~, *stx*~2c~              \+                T                                                −                                          6
  A40      Bovine   2002   I/II                                    *stx*~2a~, *stx*~2c~             \+                T                                                \+                                         1
  A45      Bovine   2007   I/II                                    *stx*~1~, *stx*~2c~              \+                T                                                −                                          16
  A48      Bovine   2008   I/II                                    *stx*~1~, *stx*~2c~              \+                T                                                −                                          6
  A51      Bovine   2002   I/II                                    *stx*~1~, *stx*~2c~              \+                T                                                −                                          6
  A60      Bovine   2003   I/II                                    *stx*~2c~                        \+                T                                                −                                          1
  A62      Bovine   2008   I/II                                    *stx*~1~, *stx*~2c~              \+                T                                                −                                          6
  A63      Bovine   2008   I/II                                    *stx*~1~, *stx*~2c~              \+                T                                                −                                          6
  A69      Bovine   2002   I/II                                    *stx*~2a~                        \+                T                                                −                                          1
  A72      Bovine   2002   I/II                                    *stx*~2a~                        \+                T                                                −                                          1
  A76      Bovine   2003   I/II                                    *stx*~2c~                        \+                T                                                −                                          5
  H02      Human    2003   II                                      *stx*~2a~                        \+                T                                                −                                          11
  H17      Human    2006   II                                      *stx*~2a~, *stx*~2c~             \+                A                                                −                                          1
  H19      Human    2006   II                                      *stx*~2c~                        \+                A                                                −                                          1
  H24      Human    2006   II                                      *stx*~2c~                        \+                A                                                −                                          5
  H32      Human    2006   II                                      *stx*~2c~                        \+                A                                                −                                          5
  H51      Human    2008   II                                      *stx*~2c~                        \+                A                                                −                                          1
  A12      Bovine   2004   II                                      *stx*~2c~                        \+                T                                                −                                          5
  A13      Bovine   2008   II                                      *stx*~2c~                        \+                A                                                −                                          5
  A16      Bovine   2006   II                                      *stx*~2c~                        \+                A                                                −                                          5
  A29      Bovine   2009   II                                      *stx*~1~, *stx*~2a~, *stx*~2c~   \+                A                                                −                                          16
  A30      Bovine   2009   II                                      *stx*~2c~                        \+                T                                                −                                          5
  A32      Bovine   2009   II                                      *stx*~1~, *stx*~2c~              \+                A                                                −                                          6
  A34      Bovine   2009   II                                      *stx*~2c~                        \+                A                                                −                                          5

Note:

Lineage-specific polymorphism assay ([@bb0325]).

*tir* (*A255T*) polymorphism assay ( [@bb0040]).

Clade 8 status of isolates assessed by SNP analysis of ECs2357 ([@bb0280]).

Shiga toxin-encoding bacteriophage insertion site assay ([@bb0295; @bb0035]).

Not applicable, the insertion site assay did not result in a SBI genotype.

###### 

Number of positions (1--17) on the chromosome of STEC O157 strains, locus on the reference genome (position (bp)), minor allele frequency (MAF), point estimate for the regression coefficient (*β*) and − log10 P-value for the SNPs on the test strains compared to the reference strain having a positive relation with the fraction adhesion to Caco-2 cells. This table shows the results for the regression model without correction for population structure, i.e. overestimating the effects.

  ID   Position (bp)   MAF    *β*    − log10 (P)
  ---- --------------- ------ ------ -------------
  1    808,227         0.05   0.31   7.55
  2    1,204,977       0.08   0.20   4.01
  3    1,265,758       0.05   0.31   7.55
  4    1,265,760       0.05   0.31   7.55
  5    1,955,401       0.08   0.20   4.01
  6    1,963,016       0.08   0.20   4.01
  7    1,965,259       0.08   0.20   4.01
  8    2,168,378       0.11   0.18   4.17
  9    2,168,379       0.11   0.18   4.17
  10   2,303,672       0.08   0.22   5.29
  11   3,115,509       0.08   0.21   4.64
  12   3,480,394       0.05   0.31   7.55
  13   3,486,443       0.08   0.21   4.73
  14   3,486,494       0.08   0.20   4.14
  15   4,929,010       0.11   0.23   7.83
  16   5,054,140       0.05   0.32   8.47
  17   5,409,931       0.08   0.21   4.64

###### 

Biological information regarding the 17 significant SNPs, obtained using a model without correction for population structure (in [Table 2](#t0010){ref-type="table"}); locus on the reference genome (position (bp)), function of this locus and description of the SNP.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ID       Position\       Locus tag\    Function                                                                  SNP description[a](#tf0030){ref-type="table-fn"}
           (bp)            Sakai                                                                                   
  -------- --------------- ------------- ------------------------------------------------------------------------- --------------------------------------------------
  1        808,227         ECs0729       RhsC protein                                                              Synonymous; C219T

  2        1,204,977       ECs1121       Prophage CP-933R tail fiber protein; putative host specificity protein    Synonymous; C1741T

  3        1,265,758       ECs1203       Antitermination protein Q                                                 Synonymous; C12T

  4        1,265,760                     Encoded by prophage CP-933R                                               Non-synonymous; G14A\
                                                                                                                   (R5Q)

  5        1,955,401       ECs1977       Phage capsid and scaffold protein                                         Synonymous; C156T

  6        1,963,016       ECs1987       Tail assembly protein                                                     Synonymous; G351C/T

  7        1,965,259       ECs1990       Prophage CP-933 V tail fiber protein; putative host specificity protein   Synonymous; C1062T

  **8**    **2,168,378**   **ECs2164**   **Minor tail protein encoded by**                                         **Non-synonymous;**

  **9**    **2,168,379**                 **Prophage CP-933O**                                                      **T424G, C425A (S142E)**

  10       2,303,672       ECs2332       [l]{.smallcaps}-Arabinose 1-dehydrogenase                                 Non-synonymous; C268A (H90N)

  11       3,115,509       Intergenic                                                                              G − \> A

  12       3,480,394       ECs3489       Phage tail fiber protein encoded by prophage CP-933P                      Synonymous; G252A

  13       3,486,443       ECs3499       Hypothetical protein                                                      Non-synonymous; T98C (L33S)

  14       3,486,494                                                                                               Non-synonymous; T149C (I50T)

  **15**   **4,929,010**   **ECs4864**   **RhsH protein**                                                          **Non-synonymous; T134C (F45S)**

  16       5,054,140       ECs4969       Putative portal protein                                                   Non-synonymous; G190A (E64K)

  17       5,409,931       ECs5283       DNA-binding transcriptional repressor UxuR                                Non-synonymous; C534A (N178K)
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note:

SNPs having a MAF ≥ 0.05 and, in bold face, MAF ≥ 0.1, i.e. ID 8, 9 and 15.

SNPs are displayed by type and position in the locus, followed in parentheses by the effect on the amino acid sequence in case of a non-synonymous SNP.

###### 

Test strains (second row) causing a 'significant' effect (MAF ≥ 0.05 in [Table 3](#t0015){ref-type="table"}) with accompanying fractional adhesion to Caco-2 cells (first row). e.g, for ID 1 the contrast of strains H24 and H19 compared to all 36 other strains gives a significant effect. For each SNP, only the major frequent allele is shown, the empty cells refer to the minor frequent allele.

  ID   Fraction adhesion   0.66   0.12   0.07   0.18   0.87   0.10   0.11   0.35   0.17   0.11   0.09   0.62
  ---- ------------------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------
  1                                                    1                                                1
  2                                                    1                                         1      1
  3                                                    1                                                1
  4                                                    1                                                1
  5                                                    1                                         1      1
  6                                                    1                                         1      1
  7                                                    1                                         1      1
  8                                      1             1                    1                           1
  9                                      1             1                    1                           1
  10                       1                    1      1                                                
  11                       1                           1             1                                  
  12                                                   1                                                1
  13                                                   1                           1                    1
  14                                                   1      1                                         1
  15                       0      0                    0                                                0
  16                       1                           1                                                
  17                       1                           1                                  1             
